FindTrial
Sign In

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-002386-38-GR
Enrollment
Unknown
Registered
2011-08-30
Start date
2011-09-30
Completion date
Unknown
Last updated
2016-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bacterial Vaginosis MedDRA version: 14.0 Level: LLT Classification code 10004055 Term: Bacterial vaginosis System Organ Class: 10021881 - Infections and infestations

Interventions

Product Name: CLINDAMYCIN/VERISFIELD VAGINAL SUPPOSITORIES 100mg Pharmaceutical Form: Vaginal delivery system INN or Proposed INN: CLINDAMYCIN PHOSPHATE CAS Number: 24729-96-2 Concentration unit: mg m

Sponsors

VERISFIELD (UK) LTD
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 200 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: Not Applicable;Primary end point(s):—

Countries

Greece

Contacts

Public ContactCLINICAL TRIALS DEPARTMENT

VERISFIELD (UK) LTD

info@verisfield.gr00302107475196

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026